Evidence map›Paper›PMID 35937275›Full record

ArticleFrontiers in public health2022

Pulmonary Cryptococcosis Diagnosed by Metagenomic Next-Generation Sequencing in a Young Patient With Normal Immune Function: A Case Report.

Yingyu Zhang, Weiliang Wang, Yingxuan Zhang, Sina Zhai, Han Xia, Xilin Zhang

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. A Critical Review of the CRISPR-Cas Technology in the Detection of SARS-CoV-2 Variants.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yingyu ZhangDepartment of Tuberculosis, Foshan Fourth People's Hospital, Foshan, China.
Weiliang WangDepartment of Tuberculosis, Foshan Fourth People's Hospital, Foshan, China.
Yingxuan ZhangDepartment of Tuberculosis, Foshan Fourth People's Hospital, Foshan, China.
Sina ZhaiDepartment of Tuberculosis, Foshan Fourth People's Hospital, Foshan, China.
Han XiaDepartment of Scientific Affairs, Hugobiotech, Beijing, China.
Xilin ZhangDepartment of Tuberculosis, Foshan Fourth People's Hospital, Foshan, China.
The Fourth People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Pulmonary cryptococcosis (PC) is a serious opportunistic fungal infection that usually occurs in immunocompromised patients. This disease is often difficult to diagnose in time due to its clinical manifestations and radiological feature similar to other pulmonary infections, as well as the low sensitivity of conventional diagnostic methods. Cryptococcosis in immune-competent patients is rare. Case Presentation: Here we report a case of PC in an immune-competent patient. Tuberculosis was suspected according to radiological features due to the positive T-lymphocyte spot test and pure protein derivative skin test. To further detect the pathogen, bronchoalveolar lavage fluid (BALF) was collected for metagenomic next-generation sequencing (mNGS). Conclusion: Metagenomic next-generation sequencing (mNGS) is a better diagnostic tool to help clinicians distinguish pulmonary cryptococcosis from other atypical pulmonary infections.

Indexed as

CryptococcosisCryptococcus neoformansPneumoniaHigh-Throughput Nucleotide SequencingHumansImmunityMetagenomicscryptococcosisCryptococcus neoformansdiagnosisimmune competent patientsmetagenomic next-generation sequencing

Identifiers

PMID35937275
PMCPMC9353032
OpenAlexW4286447704

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.